Virginia governor critical of Trump’s coronavirus response in first appearance since testing positive

About 65 staff members who had close contact with the Northams were told to ­self-isolate for two weeks. Northam said none tested positive, which he called “a testament” to the value of wearing masks.

He noted that masks protected several staff members who could not physically distance from him before he tested positive, including a press secretary, photographer and security detail who traveled in an SUV and airplane with Northam.

He contrasted that with the largely mask-free Rose Garden ceremony last month that Anthony S. Fauci, the nation’s top infectious-disease expert, has called a superspreader event. Trump, first lady Melania Trump and several others subsequently tested positive for the virus.

“No masks, no social distancing — and look at the number of people that tested positive,” Northam said Tuesday, referring to the White House event. “We talk about science, it doesn’t get any clearer than that . . . I would remind every Virginian: Masks are scientifically proven to reduce the spread of this disease, plain and simple.”

Northam, a former Army doctor and pediatrician, said his and his wife’s symptoms were mild. He warned Virginians not to let down their guard, particularly as cooler fall temperatures and shrinking daylight hours make outdoor socializing less appealing.

The governor said he is unlikely to ease pandemic-related restrictions in the near term. He acknowledged pressure to return to in-person education at public schools but urged continued caution.

“Numbers are going up in a number of states across this country, so we’re not out of the woods,” he said. “We’re nowhere close to being out of the woods.”

The greater Washington region on Tuesday reported 1,763 additional coronavirus cases and 20 deaths. Virginia added 1,235 cases and 11 deaths, Maryland added 482 cases and nine deaths, and the District added 46 cases and no deaths.

Virginia’s daily caseload was above its rolling seven-day average, lifting that number to 1,089 — the state’s highest daily average since Aug. 13.

The seven-day average in Northern Virginia rose Tuesday to 264 cases, a four-month high in the region.

Daily caseloads Tuesday in Maryland and the District were below their rolling seven-day averages. It’s the third consecutive day that both jurisdictions reported new infections at or below their recent average amid an uptick that began earlier this month.

The recent caseload rise across the region has coincided with the outbreak at the White House, although local health officials have said it’s unclear whether there’s a connection.

Dana Hedgpeth contributed to this report.

Source Article

Trump campaign manager returns to office 10 days after positive COVID-19 test

President TrumpDonald John TrumpDes Moines mayor says he’s worried about coronavirus spread at Trump rally Judiciary Committee Democrats pen second letter to DOJ over Barrett disclosures: ‘raises more questions that it answers’ Trump asks campaign to schedule daily events for him until election: report MORE‘s campaign manager Bill StepienBill StepienTrump Jr. returning to campaign trail after quarantining The Memo: Trump searches for path to comeback Bob Dole claims no Republicans on debate commission support Trump MORE resumed working at the campaign’s Virginia headquarters on Monday, 10 days after he tested positive for COVID-19.

Stepien told reporters on a conference call that he was back in the office after his recent positive test, “in full accordance with” Centers for Disease Control and Prevention (CDC) guidelines.

The CDC guidelines say adults with mild to moderate COVID-19 cases can be around others 10 days after the onset of symptoms so long as they have gone 24 hours without a fever and other symptoms are improving. Severe cases require longer isolation periods. Public health experts have also encouraged individuals to obtain two negative tests before resuming regular activities.

Stepien, 42, tested positive on Oct. 2 and dealt with mild flu-like symptoms, the campaign said at the time. He went into quarantine and worked from home until Monday.

Stepien did not say on Monday’s call whether he had tested negative for the virus but cited being beyond the 10 day window from the onset of symptoms for his decision to return to the office.

“We take a lot of precautions here at the headquarters every single day,” Stepien said, pointing to signage about health protocols and noting that the campaign has a nurse on staff to ensure everyone is healthy.

Stepien’s decision to resume working in-person reflects the broader attitude of the president and his team toward the virus, which has killed more than 210,000 people in the U.S. and infected nearly 8 million.

Trump, who revealed that he had tested positive for the coronavirus on Oct. 2, is set to resume campaign rallies on Monday night in Florida despite the White House refusing to say when he last tested negative, and some top White House officials, such as chief of staff Mark MeadowsMark Randall MeadowsAdministration officials call on Congress to immediately pass bill to spend unused PPP funds Trump claims he is ‘immune’ from coronavirus, defends federal response Senate Republicans rip new White House coronavirus proposal MORE, have continued to work from the building despite being in close contact with the president, press secretary Kayleigh McEnany and others who have tested positive. 

The president’s physician said late Saturday that Trump is no longer a risk to spread the virus but stopped short of saying he had tested negative.

Source Article

Fitness App Market will Showcase Positive Impact during 2020-2024 | Increasing Demand for Wearable Devices to Boost the Market Growth

Technavio has been monitoring the fitness app market and it is poised to grow by USD 1.68 bn during 2020-2024, progressing at a CAGR of almost 12% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201008005641/en/

Technavio has announced its latest market research report titled Global Fitness App Market 2020-2024 (Graphic: Business Wire)

Technavio’s in-depth research has all your needs covered as our research reports include all foreseeable market scenarios, including pre- & post-COVID-19 analysis. We offer $1000 worth of FREE customization

The market is fragmented, and the degree of fragmentation will accelerate during the forecast period. adidas AG, ASICS Digital Inc., Azumio Inc., BetterME., FitNow Inc., Google LLC, Nike Inc., Samsung Electronics Co. Ltd., Under Armour Inc., and YAZIO GmbH are some of the major market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.

View market snapshot before purchasing

Increasing demand for wearable devices has been instrumental in driving the growth of the market.

Technavio’s custom research reports offer detailed insights on the impact of COVID-19 at an industry level, a regional level, and subsequent supply chain operations. This customized report will also help clients keep up with new product launches in direct & indirect COVID-19 related markets, upcoming vaccines and pipeline analysis, and significant developments in vendor operations and government regulations. Download a Free Sample Report on COVID-19 Impacts

Fitness App Market 2020-2024: Segmentation

Fitness App Market is segmented as below:

  • Gender

  • Application

    • Lifestyle Monitoring

    • Health Monitoring

    • Others

  • Geographic Landscape

    • APAC

    • North America

    • Europe

    • South America

    • MEA

Fitness App Market 2020-2024: Scope

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. The fitness app market report covers the following areas:

This study identifies proliferation of a variety of fitness apps as one of the prime reasons driving the fitness app market growth during the next few years.

Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavio’s in-depth research has direct and indirect COVID-19 impacted market research reports.

Register for a free trial today and gain instant access to 17,000+ market research reports.

Technavio’s SUBSCRIPTION platform

Fitness App Market 2020-2024: Key Highlights

  • CAGR of the market during the forecast period 2020-2024

  • Detailed information on factors that will assist fitness app market growth during the next five years

  • Estimation of the fitness app market size and its contribution to the parent market

  • Predictions on upcoming trends and changes in consumer behavior

  • The growth of the fitness app market

  • Analysis of the market’s competitive landscape and detailed information on vendors

  • Comprehensive details of

Stephen Miller Tests Positive as White House Outbreak Grows

Here’s what you need to know:

Credit…Anna Moneymaker for The New York Times

On Tuesday evening, senior administration officials confirmed that Stephen Miller, Mr. Trump’s top speechwriter and a policy adviser, had tested positive for the coronavirus, joining a growing list of Mr. Trump’s close aides who have the virus.

“Over the last five days I have been working remotely and self-isolating, testing negative every day through yesterday,” Mr. Miller said in a statement. “Today, I tested positive for Covid-19 and am in quarantine.”

Mr. Miller is married to Katie Miller, Vice President Mike Pence’s communications director. A senior administration official said Ms. Miller, who contracted the virus this spring and returned to work in May, was tested Tuesday morning and was negative for any new infection.

On Tuesday, many White House offices were empty as officials stayed home to wait out the infectious period from an outbreak of the coronavirus within the building and among people who had been there.

President Trump was in the White House residence, convalescing, as a number of advisers and other officials stayed home, either because they had contracted the coronavirus or had been near people who did.

The White House communications and press shops were bereft of people. The White House press secretary, Kayleigh McEnany, announced on Monday that she had tested positive. Two other press office aides have also contracted the virus, and two more aides on Tuesday were said to have tested positive, people familiar with the results said.

The outbreak in the White House, which has extended to some lawmakers on Capitol Hill, has raised concerns in the city that surrounds it. Washington, D.C., which has managed to bring infection rates down in recent weeks through preventive laws and high rates of compliance, has almost no control over the federal government.

The city reported 105 new coronavirus cases on Tuesday, the highest number since June 3.

The gathering at the Rose Garden would have violated the city’s mandates limiting the size of gatherings and requiring masks. But because the White House is on federal property, it is exempt from such rules.

City officials said they would be closely monitoring infection trends for several days to see if the Capitol and White House cases affected the city’s overall infection rate.

Credit…Doug Mills/The New York Times

The White House physician, Dr. Sean P. Conley, said on Tuesday that President Trump was experiencing no symptoms of Covid-19 and doing “extremely well” on his first full day at home since a three-night stay in the hospital.

But outside doctors and medical experts in Covid-19 and lung disease said they were struggling to piece together an accurate picture of Mr. Trump’s health. Far from having vanquished Covid-19, the outside experts said, Mr. Trump is most

VA Coronavirus Hospitalizations Top 1K, Positive Rate Below 5%

VIRGINIA — The Virginia Department of Health reported 509 new cases of the coronavirus on Wednesday, down from 625 new cases on Tuesday. In Virginia, there have been 153,691 cumulative coronavirus cases, 11,345 hospitalizations and 3,303 deaths.

COVID-19 hospitalizations stand at 1,003 patients statewide as of Wednesday, the first time they have climbed above 1,000 since Sept. 16 when they reached 1,027. That includes 240 in the central region, 234 in the eastern region, 217 in the northern region, 194 in the southwest region and 118 in the northwest region.

According to the Virginia Hospital & Healthcare Association, the current hospitalizations include 228 in the intensive care units and 109 on ventilators.

Ventilator use stands at 22 percent among all Virginia hospital patients, and ICU occupancy is at 80 percent. There are no hospitals reporting difficulty obtaining personal protective equipment in the next 72 hours. According to the association, 18,189 COVID-19 total patients have been discharged from hospitals as of Wednesday.

The seven-day average of new coronavirus cases has been below 1,000 since Sept. 18 and now stands at 774. On Wednesday, the southwest region led the state with 124 new cases of the coronavirus, followed by the northern region with 124 cases, the northwest region with 81, the central region with 65 and the eastern region with 58.

The seven-day positive average of PCR tests in Virginia is 4.8 percent as of Oct. 3. The regional averages are 4.4 percent in the northern region, 4.5 percent in the central region, 4.6 in the eastern region, 4.9 percent in the northwest region and 6.4 percent in the southwest region. There have been 2,170,313 PCR tests completed as of Wednesday, an increase of 26,145 from Tuesday.

Here are the latest coronavirus data updates for our coverage area between Tuesday and Wednesday:

  • Alexandria: 3,938 cases, 327 hospitalizations, 71 deaths; increase of six cases

  • Arlington County: 4,083 cases, 508 hospitalizations, 152 deaths; increase of 15 cases

  • Fairfax County: 21,447 cases, 2,180 hospitalizations, 594 deaths; increase of 33 cases and two deaths; removal of one hospitalization

  • Fairfax City: 140 cases, 13 hospitalizations, eight deaths; removal of one hospitalization

  • Falls Church: 72 cases, 13 hospitalizations, seven deaths; no changes

  • Loudoun County: 7,042 cases, 441 hospitalizations, 127 deaths; increase of 16 cases and one death

  • Manassas: 1,961 cases, 130 hospitalizations, 24 deaths; increase of seven cases

  • Manassas Park: 619 cases, 56 hospitalizations, eight deaths; increase of three cases and one hospitalization

  • Prince William County: 12,855 cases, 931 hospitalizations, 208 deaths; increase of 44 cases

  • Fredericksburg: 554 cases, 50 hospitalizations, five deaths; increase of one case

  • Spotsylvania County: 2,197 cases, 137 hospitalizations, 46 deaths; increase of two cases and one hospitalization

  • Stafford County: 2,082 cases, 161 hospitalizations, 18 deaths; increase of one case

RELATED:

This article originally appeared on the Ashburn Patch

Source Article

China’s Experimental COVID-19 Vaccine Earns Positive Early Reviews

KEY POINTS

  • A Chinese experimental coronavirus vaccine being developed by the Institute of Medical Biology was shown to be safe in an early stage clinical trial
  • Researchers reported no severe adverse reactions from the injection
  • Most notably, the vaccine proved to be effective and induced an immune response within vaccine recipients

A Chinese experimental coronavirus vaccine being developed by the Institute of Medical Biology was shown to be safe in an early stage clinical trial, researchers said. 

The potential vaccine is currently in phase one of clinical trials and 191 healthy participants aged between 18 and 59 were given the experimental shot. Researchers reported no severe adverse reactions from the injection but only mild pain, slight fatigue, and redness, itching, and swelling at the injection site.

Most notably the vaccine proved to be effective and induced an immune response within vaccine recipients. 

“All the data obtained in this trial support the safety and immunogenicity of this inactivated vaccine and are encouraging with regard to further studies of its efficacy in the future,” researchers said.

China has vaccinated hundreds of thousands of essential workers and other groups considered at high risk with other vaccines, even as clinical trials had not been fully completed, raising safety concerns among experts.

Aside from China’s vaccine development, there have been other positive signs in the vaccine world.

The European Medicines Agency accelerated the approval process for a Covid-19 vaccine developed by BioNTech and Pfizer. This will allow rapid authorization once the vaccine is deemed safe and clears clinical trials. 

The decision by the EU regulator was based on preliminary results from the companies’ early clinical trials, which showed the vaccine triggers an immune response in adults. 

Albert Bourla, Pfizer’s CEO, previously argued that the pharmaceutical conglomerate could have its vaccine results from its late-stage coronavirus vaccine trial as early as October.  In late July, Pfizer already enrolled 23,000 volunteers in its phase three trial but aims to expand to 44,000 participants to obtain more well-rounded results. 

“We expect by the end of October, we should have enough … to say whether the product works or not,” Bourla said. 

U.S. health officials previously argued that results from late-stage vaccine trials could come in November, if not sooner.

Source Article

In a few days, more people in Trump’s orbit tested positive for coronavirus than in all of Taiwan

Trump announced his positive test early Friday, and was admitted to Walter Reed National Military Medical Center later that day. He returned Monday to the White House, where he removed his mask, despite doctors saying he was still contagious.

Meanwhile, Taiwan — the self-ruled island home to 23 million people — reported just eight new cases in the past week.

More than a dozen countries have reported fewer than 10 new coronavirus cases in the past seven days, including several that have not reported any cases at all. Not all such case numbers are reliable. Some countries are facing serious testing shortages. Others stand accused of avoiding public disclosure of their case numbers. But Taiwan has been widely praised for its handling of the coronavirus pandemic.

Late last year, as word of an unusual respiratory illness in the Chinese city of Wuhan began to spread, Taiwanese officials scrambled to start screening passengers arriving from the city as early as Dec. 31. In January, a Taiwanese health official raised serious alarm about the virus in an attempt to warn the rest of the world about what could come next.

But it was months before many other governments realized the virus was set to upend the world as we know it.

As hospital wards became overwhelmed in hot spots across the globe, Taiwan — which was prepared to launch intensive contact-tracing initiatives — has managed to avoid the worst of the pandemic. The island has confirmed just 521 coronavirus cases and seven deaths, according to a Johns Hopkins University tally. The vast majority of cases have not been domestically transmitted.

In August, Health and Human Services Secretary Alex Azar visited the island, where he commended officials for their fast response to the pandemic, calling it “world-class.” Speaking to reporters in Taipei, Azar told reporters that Taiwan acted quickly in part because it had been “scarred” by Beijing’s handling of the SARS outbreak nearly two decades earlier.

Elsewhere, numbers are a bit cloudier.

Several countries reporting fewer than 10 cases in the past week are located in sub-Saharan Africa, including some that did not report any new cases to the World Health Organization. Although many countries in Africa appear to have fared far better against the virus than experts initially suggested they might, in some places, testing shortages or other factors could be affecting case counts.

Experts have questioned the caseload in Tanzania, for example, where President John Magufuli has insisted that the country’s outbreak is “absolutely finished.”

And when it comes to cloudy numbers, the same holds true for how many infections may trace their roots back to the White House. Numerous guests who attended the Rose Garden event told The Washington Post they have not been subject to a contact-tracing effort.

And Trump’s behavior since his diagnosis — including his decision to leave the hospital to drive past his supporters and to remove his mask upon return to the White House on Monday — has stunned epidemiologists, who fear he continues

Can-Fite Announces Positive Phase III Psoriasis Interim Data Analysis

  • Independent Data Monitoring Committee (IDMC) conducted a pre-planned interim analysis of the Company’s Phase III Comfort™ trial of Piclidenoson for the treatment of psoriasis and recommended to continue with this psoriasis study

  • A separate IDMC for the pre-planned interim analysis of the Acrobat™ Rheumatoid Arthritis (RA) Phase III study recommended not to continue this study. The Company plans to undertake a detailed analysis of the data of the RA study and decide on the next steps.

Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today announced that the Independent Data Monitoring Committee (IDMC) which conducted an interim analysis of the Company’s Phase III Comfort™ trial of Piclidenoson in the treatment of moderate-to-severe plaque psoriasis, recommended, based on the positive data, to continue the study with the original sample size and drop one dose group. This means that an optimal dose has been found and that the study can be concluded earlier than has been originally planned.

A separate IDMC for the interim analysis of the Acrobat™ Rheumatoid Arthritis Phase III study recommended not to continue this study. The Company plans to undertake a detailed analysis of the data of the RA study and decide on the next steps.

Can-Fite’s Comfort™ Phase III psoriasis study is designed to establish Piclidenoson’s superiority compared to placebo and non-inferiority compared to Apremilast (Otezla®) in patients with moderate to severe plaque psoriasis. The randomized, double blind study is being conducted in Europe, Israel, and Canada. Patients were randomized into four groups: 2 mg Piclidenoson, 3 mg Piclidenoson, Otezla®, and placebo. The study’s primary endpoint is the proportion of patients who achieve a PASI score response of ≥75% (PASI 75) vs. placebo at week 16. The secondary endpoints include non-inferiority to Otezla® on weeks 16 and 32.

“While the interim analysis data continue to be blinded to Can-Fite, and the results have only been available to the IDMC, their recommendation to continue the Phase III psoriasis study and also to drop one of the dosing groups are highly encouraging. There is a real market need for an efficacious and safe oral drug for this devastating disease. We thank the members of both of the IDMCs for their diligence in reviewing our Phase III interim data and for making their recommendations.” stated Can-Fite CEO Dr. Pnina Fishman.

The majority of costs associated with the Phase III Comfort™ study were previously paid, and based on the Company’s current cash and its anticipated uses, the Company believes it has sufficient runway to cover the completion of this study.

Piclidenoson has been out-licensed for the indication of psoriasis in Canada, South Korea, Spain, Austria, Switzerland, Hong Kong, Macau, Taiwan, and China. According to iHealthcareAnalyst, the psoriasis therapeutic market is estimated to reach $11.3 billion by 2025.

About Piclidenoson

Piclidenoson is a novel, first-in-class, A3 adenosine receptor agonist (A3AR) small molecule, orally bioavailable drug with a favorable therapeutic index demonstrated in Phase

North Carolina elementary school teacher dies days after testing positive for Covid-19

Julie Davis, who taught at Norwood Elementary School in Stanly County, died from Covid-19 related complications, according to Michelle Bailey, a spokeswoman for the Stanly County School District. While the official cause of death hasn’t been released, Bailey confirmed Davis’ diagnosis.

“We are extending our deepest condolences to Mrs. Davis’ family,” the district said. “We were truly blessed by her professionalism and caring spirit.” A family member told CNN affiliate WSOC that Davis was one of the “hardest workers and that she was compassionate, caring, thoughtful and someone who loved to the depths of her soul.”

Davis began experiencing symptoms on September 25th and immediately self-quarantined, Bailey said.

On September 29th, the Stanly County Health Department notified parents of the teacher’s third grade class that they were required to quarantine for 14 days after being exposed to a staff member who had tested positive for the coronavirus.

Bailey told CNN the staff member was indeed Davis. CNN reached out to the North Carolina Office of Medical Examiner for confirmation of cause of death but we haven’t heard back.

None of the quarantined students have developed any symptoms or tested positive, Bailey said. The health department told the administration it believed Davis did not contract the virus from the school.

The return to remote learning this fall came with system outages, cyberattacks and other problems

Davis taught at Norwood Elementary School for two years, and she had earned a reputation as an “inspirational teacher who was always seeking ways to support every student so that they were able to fulfill their potential,” the district said in a Facebook post.

“Students absolutely loved being taught by Mrs. Davis,” the district said. “Her personality was infectious and she brought joy into the lives of the students, staff, and community.”

For the third time in less than a week, North Carolina is reporting more than 2,200 new Covid-19 cases, according to data released by the North Carolina Department of Health. On Monday, the state reported 2,258 additional infections related to the coronavirus, the state’s department of health reported.
North Carolina college student, seemingly otherwise healthy, dies of Covid-19 complications

North Carolina currently has the eighth highest number of cases in states across the US, according to data by Johns Hopkins University.

The total number of cases across the state to date is 219,754, with 3,637 Covid-19 related fatalities, the DOH said.

There have been at least 7,433,828 coronavirus cases in US overall and at least 209,928 deaths.

Source Article

Trump kept quiet about 1st positive COVID-19 test

When President Trump called into Fox News on Thursday night and confirmed his close aide Hope Hicks tested positive for COVID-19, he didn’t share with viewers that he also had a positive result from a rapid test and was waiting for the results from a more thorough screening, several people familiar with the matter told The Wall Street Journal on Sunday.

Speaking to host Sean Hannity, Trump said he had been tested and would get the results back “either tonight or tomorrow morning.” Early Friday morning, Trump tweeted that both he and first lady Melania Trump had tested positive for coronavirus.

When Hicks tested positive on Thursday morning, Trump’s top advisers wanted to make sure this was kept under wraps, and even his campaign manager, Bill Stepien, didn’t find out until it was reported by Bloomberg News on Thursday night, people familiar with the matter told the Journal; Stepien announced on Friday morning that he tested positive for the virus. Per the Journal, Trump told another unnamed adviser that they should keep their positive test results to themselves, saying, “Don’t tell anyone.”

On Thursday afternoon, Trump left Washington for a fundraising event in New Jersey. One official told the Journal the campaign squad was not consulted on whether Trump should attend the event, and the White House has since said the operations team determined it was safe to go, since Trump tested negative in the morning. Holding this fundraiser “in spite of knowing that one of the team was infected and had exposed others was a recipe for spreading disease,” Lisa M. Lee, a public health expert at Virginia Tech University, told the Journal.

More stories from theweek.com
7 insanely funny cartoons about the chaotic first debate
Doctor slams Trump for leaving hospital to drive by supporters: ‘The irresponsibility is astounding’
White House doctor says he left out details of Trump’s illness to reflect president’s ‘upbeat attitude’

Source Article